Expediting the chromatographic analysis of COVID-19 antibody therapeutics with ultra-short columns, retention modeling and automated method development.

Duivelshof, Bastiaan; Zöldhegyi, Arnold; Guillarme, Davy; Lauber, Matthew; Fekete, Szabolcs

Duivelshof, Bastiaan; Zöldhegyi, Arnold; Guillarme, Davy; Lauber, Matthew; Fekete, Szabolcs.

Afiliação

Duivelshof B; Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Geneva, Switzerland; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Zöldhegyi A; Molnár Institute, Berlin, Germany.
Guillarme D; Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Geneva, Switzerland; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Lauber M; Waters Corporation, Milford, MA, USA.
Fekete S; Waters Corporation, Geneva, Switzerland. Electronic address: Szabolcs_Fekete@waters.com.

J Pharm Biomed Anal ; 221: 115039, 2022 Nov 30.

Article em En | MEDLINE | ID: mdl-36115204

Assuntos

Tratamento Farmacológico da COVID-19; Anticorpos Monoclonais/uso terapêutico; Humanos; Pandemias; SARS-CoV-2

Palavras-chave

Automation; Casirivimab; Covid-19; Imdevimab; Retention modeling; Ultra-short column

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google